USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$119.16B
Market Cap
25.66
P/E Ratio
3.62
EPS
$94.71
52 Week High
$77.56
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $22B |
Total Revenue | $34B |
Cost Of Revenue | $12B |
Costof Goods And Services Sold | $12B |
Operating Income | $6B |
Selling General And Administrative | $11B |
Research And Development | $2.7B |
Operating Expenses | $16B |
Investment Income Net | - |
Net Interest Income | -$729M |
Interest Income | $612M |
Interest Expense | $729M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.9B |
Income Before Tax | $5.6B |
Income Tax Expense | $936M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $4.7B |
Comprehensive Income Net Of Tax | - |
Ebit | $6.4B |
Ebitda | $9.2B |
Net Income | $4.7B |
Field | Value (USD) |
---|---|
Total Assets | $92B |
Total Current Assets | $24B |
Cash And Cash Equivalents At Carrying Value | $2.2B |
Cash And Short Term Investments | $2.2B |
Inventory | $5.5B |
Current Net Receivables | $6.5B |
Total Non Current Assets | $68B |
Property Plant Equipment | $7.9B |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $12B |
Intangible Assets Excluding Goodwill | $12B |
Goodwill | $42B |
Investments | - |
Long Term Investments | - |
Short Term Investments | $6.7B |
Other Current Assets | $2.9B |
Other Non Current Assets | - |
Total Liabilities | $43B |
Total Current Liabilities | $13B |
Current Accounts Payable | $2.4B |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $2.9B |
Total Non Current Liabilities | $31B |
Capital Lease Obligations | $58M |
Long Term Debt | $26B |
Current Long Term Debt | $2.9B |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $29B |
Other Current Liabilities | $7.6B |
Other Non Current Liabilities | $1.8B |
Total Shareholder Equity | $48B |
Treasury Stock | - |
Retained Earnings | $31B |
Common Stock | $128K |
Common Stock Shares Outstanding | $1.3B |
Field | Value (USD) |
---|---|
Operating Cashflow | $7B |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $2.9B |
Capital Expenditures | $1.9B |
Change In Receivables | - |
Change In Inventory | -$292M |
Profit Loss | - |
Cashflow From Investment | -$1.9B |
Cashflow From Financing | -$4.4B |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $3.6B |
Dividend Payout Common Stock | $3.6B |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$3.2B |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $4.7B |
Field | Value (USD) |
---|---|
Gross Profit | $22B |
Total Revenue | $34B |
Cost Of Revenue | $12B |
Costof Goods And Services Sold | $12B |
Operating Income | $6B |
Selling General And Administrative | $11B |
Research And Development | $2.7B |
Operating Expenses | $16B |
Investment Income Net | - |
Net Interest Income | -$729M |
Interest Income | $612M |
Interest Expense | $729M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.9B |
Income Before Tax | $5.6B |
Income Tax Expense | $936M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $4.7B |
Comprehensive Income Net Of Tax | - |
Ebit | $6.4B |
Ebitda | $9.2B |
Net Income | $4.7B |
Field | Value |
---|---|
Ex Dividend Date | 2025-09-26 |
Declaration Date | 2025-08-14 |
Record Date | 2025-09-26 |
Payment Date | 2025-10-17 |
Amount | 0.71 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.